Abstract
Lipopolysaccharide-binding protein (LBP) has a well-established role in Gram-negative infection. New data suggest a more expanded role for LBP as a general recognition molecule. Several bacterial surface components from Gram-positive pathogens are also recognized by this molecule. LBP may also serve as a clinical marker in severe infections and may carry therapeutic potential.
MeSH terms
-
Acute-Phase Proteins / immunology
-
Acute-Phase Proteins / metabolism*
-
Bacterial Infections / immunology
-
Carrier Proteins / immunology
-
Carrier Proteins / metabolism*
-
Humans
-
Immunity, Innate*
-
Lipopolysaccharides / immunology
-
Lipopolysaccharides / metabolism
-
Membrane Glycoproteins / immunology
-
Membrane Glycoproteins / metabolism*
-
Mycoses / immunology
Substances
-
Acute-Phase Proteins
-
Carrier Proteins
-
Lipopolysaccharides
-
Membrane Glycoproteins
-
lipopolysaccharide-binding protein